Francesco Spagnolo

8PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycologyMolecular targetsReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 07, 2024
Real-world multicentre observational study of effectiveness and toxicity in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.

L Faoro, V Salizzato, M Coppola

|Mar 07, 2024
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study.

Jason J Luke, Paolo A Ascierto, Muhammad A Khattak

|Feb 24, 2024
Primary endobronchial melanoma: a case report and clinical management indications.

Emanuela Barisione, Andrea Boutros, Marco Mora

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|May 22, 2021
Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review.

Francesco Spagnolo, Andrea Boutros, Elena Croce

Pageof 2